why choose us

Clinical Trials Search

Showing 4,010 of 132,656 result(s)
Shoulder Proprioception: a Comparative Study on Hand Dominance and Sex

Status: COMPLETED

Condition: Position Sense

Interventions: A Cybex brand isokinetic dynamometer [Cybex NORM®, Humac, CA, USA] was used for shoulder proprioception assessment.
Active Joint Position Sensati

Date: 2024-09-17

Prediction of MMSE Scores for Cognitive Impairment

Status: COMPLETED

Condition: Cognitive Impairment

Interventions: A dataset comprising participants with MMSE scores of ?26 and 30 will be used to evaluate the classification performance of various machine learning t

Date: 2024-09-17

The Effect of Watching Short Videos on Preoperative Anxiety

Status: COMPLETED

Condition: Anesthesia

Interventions:

Date: 2024-09-17

A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health

Status: COMPLETED

Condition: Dental Plaque

Interventions: 0.454% Stannous Fluoride, 0.3% Zinc Chloride,1% Alumina toothpaste containing 1100 parts per million (ppm) fluoride.

Date: 2024-09-17

Evaluate the Impact of the Combination of 3 Probiotic Strains on Quality of Life and Symptoms in Peri- and Postmenopausal Women

Status: COMPLETED

Condition: Menopause

Interventions: Combination of Levilactobacillus brevis KABP-052, Lactiplantibacillus plantarum KABP-051 and Pediococcus acidilactici KABP-021 in concentration of 1E0

Date: 2024-09-17

Physical Activity Level and Sleep Quality in Type 2 Diabetes

Status: COMPLETED

Condition: Type 2 Diabetes Mellitus (T2DM)

Interventions: Analysis of routine biochemical parameters

Date: 2024-09-17

Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer

Status: COMPLETED

Condition: Breast Cancer
Triple Negative Breast Cancer

Interventions: DRUG: Pembrolizumab - Pembrolizumab 200 mg administered every three weeks intravenously on day 1 of each cycle.
DRUG: Carboplatin - Carboplatin:

Date: 2024-09-17

A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Status: COMPLETED

Condition: Obesity
Overweight

Interventions: DRUG: LY3841136 - Administered SC
DRUG: Tirzepatide - Administered SC
DRUG: Placebo - Administered SC

Date: 2024-09-17

Effects Of Daily Taurine Intake For 6 Months On Biological Age and Body Metabolism Indicators As Well As Physical Fitness In 55-75-year-old Women And Men

Status: COMPLETED

Condition: Taurine

Interventions: Intervention group (4g of taurine;day): 2g of taurine (4 capsules, 500mg each) in the morning and 2g of taurine (4 capsules, 500mg each) in the e

Date: 2024-09-17